Is COVID-19 altering how pharma engages with HCPs?

In May and June, Accenture surveyed 120 general practitioners, oncologists, cardiologists and immunologists in each of the following six countries: China, France, Germany, Japan, the U.K., and the U.S. to understand how healthcare provider operations and needs have changed during COVID-19, and which of these changes will have long-lasting implications for how healthcare providers [...]

Choosing the Right Medical Communications Agency.

Medical Communications (MedComms) agencies have roots in medical education, and typically focus their activities around informing healthcare professionals (HCPs) about the risks and benefits of new therapies or treatments. They conceptualize, design and produce medical and scientific materials such as slide decks, conference posters, publications and abstracts for a variety of outlets and channels – [...]

Leading the way: How the Pharmaceutical industry can benefit from digital transformation with a new strategic approach for Publication Planning.

There is an increasing need to quickly publish emerging clinical evidence supporting novel treatments and medications and extend the reach of key medical claims to new target audiences. You may also like: Why You Need a Medical Communications Company for Publication Planning. It’s estimated $58.8 billion USD is invested every year in R&D by pharma [...]

How Working with a Medical Communications Agency Can Improve Outcomes of Your Next Scientific Congress Symposium

Sponsoring a congress symposium is a highly effective method for pharmaceutical companies to share the latest data and hot topics with healthcare professionals (HCPs).  A symposium enables pharmaceutical companies, key opinion leaders (KOLs) and HCPs to discuss new research, relevant findings, best practices and future activities in an interactive atmosphere with a large audience.  Selecting [...]

Why You Need a Medical Communications Company for Publication Planning

Publication planning is one of the most important components of a communications strategy for a drug or device, and it forms the base upon which pharma companies can share key scientific data on a product and spread awareness. A requirement in many countries, publishing critical data from clinical trials informs key external stakeholders of a [...]

Meet an SDM Team Member: Patrick Pathammavong

At Six Degrees Medical (SDM), we take the work we do very seriously. As experts in medical communications, we understand that our contributions help our clients to deliver life-changing pharmaceutical treatments into the hands of the patients who need them most. We’re driven by a purpose bigger than simply punching the clock in a 9 [...]

eLearning Evolves into Multimodal Digital Learning in 2019

The word “eLearning” has come so far since it was first coined in 1999.[1] Twenty years later, eLearning reaches far beyond the confines of the simple lowercase “e” for electronic. It is highly adaptable, often social and usually competitive. Continuing technological advances in virtual reality, augmented reality, artificial intelligence, and more are transforming the learning [...]

Pharma Trends: What to Expect in 2019

Trends to watch in 2019 include an increasing emphasis on highly targeted drugs; new healthcare applications for artificial intelligence (AI) and machine learning (ML); eMeeting innovations; and pressure to reduce drug prices while improving patient outcomes. The following is a round-up of what we’re expecting to see this year: Outcome-Based Care Payers, healthcare professionals and [...]

The FDA’s Streamlined Drug Approval Process: What You Need to Know

Major news from 2018 was the FDA’s announcement of upcoming changes to  the processes of the drug review office. Included in the modernization, per a written statement[1] from the FDA Commissioner Scott Gottlieb, is to provide FDA scientists and medical officers the opportunity to become “thought leaders”[2] in their fields. The proposals for change include [...]

Load More Posts